Laryngeal Cancer · Symptoms & diagnosis

What are the early signs of laryngeal cancer?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Laryngeal Cancer Answer length: short, citable
Quick answer

The common early signs are hoarseness or a change in voice lasting more than 2–3 weeks (classic for glottic cancer), persistent sore throat, pain on swallowing or pain referred to one ear, a lump in the neck (more typical of supraglottic tumours) and difficulty swallowing, choking or coughing when eating. Head and neck tumours often cause mild, one-sided symptoms that mimic a cold, a dental problem or a sore throat. Any symptom in the head or neck that persists for more than two to three weeks needs an ENT examination rather than repeated antibiotics.

In detail

Early disease can be painless, which is why the "two-to-three-week rule" is used: a persistent lump, ulcer, hoarseness, unilateral ear pain, nasal obstruction or swallowing change should be examined with an endoscope by an ENT or head and neck specialist.

Do not wait for pain. Pain is usually a later feature in head and neck oncology, and delay in diagnosis is one of the strongest modifiable predictors of stage at presentation.

  • Hoarseness or a change in voice lasting more than 2–3 weeks (classic for glottic cancer)
  • Persistent sore throat, pain on swallowing or pain referred to one ear
  • A lump in the neck (more typical of supraglottic tumours)
  • Difficulty swallowing, choking or coughing when eating
  • Coughing up blood, noisy breathing (stridor) or progressive breathlessness in advanced disease
  • Unexplained weight loss and reduced exercise tolerance

What this means in practice: this answer is part of the “Symptoms & diagnosis” section of the Laryngeal Cancer topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about laryngeal cancer

See all 14 questions in this topic →

Sources for this answer

  1. Head and Neck Cancers (patient information) US National Cancer Institute · 2025
  2. About Head and Neck Cancer American Cancer Society · 2025
  3. Global Cancer Observatory (GLOBOCAN 2022) International Agency for Research on Cancer / WHO · 2022 · Source of worldwide and country-level incidence and mortality estimates.
  4. Global Cancer Facts & Figures, 5th Edition (GLOBOCAN 2022 tables) American Cancer Society · 2024
  5. Nivolumab Risk Management Plan — epidemiological characteristics of SCCHN (GLOBOCAN 2022 summary) European Medicines Agency · 2025 · Reports the combined 947,211 head and neck cancer cases in 2022 and regional ASRs.
  6. Global burden and international trends in laryngeal cancer incidence (GLOBOCAN 2022 and CI5-XII) Japanese Journal of Clinical Oncology / registry-based review · 2025

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.